AKT1 and Insulin resistance: Similarly, this study demonstrates for the first time that TTE and its major constituents reduced PEPCK and G6Pase levels and activated Akt/AMPK, resulting in improved insulin resistance and hepatic gluconeogenesis in both in vitro and in vivo.